Nanae Nagata Selected Research

Nanae Nagata Research Topics

Disease

7	Inflammation (Inflammations) 01/2023 - 03/2011
2	Normal Pressure Hydrocephalus 01/2024 - 04/2014
2	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 01/2023 - 01/2023
2	Edema (Dropsy) 01/2023 - 01/2019
2	Asthma (Bronchial Asthma) 09/2021 - 01/2021
2	Food Hypersensitivity (Food Allergy) 01/2021 - 01/2019
2	Colitis 01/2021 - 03/2011
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2021 - 05/2009
2	Wasting Syndrome (Wasting Disease) 01/2020 - 05/2009
2	Infections 01/2019 - 06/2012
2	Body Weight (Weight, Body) 01/2019 - 03/2009
1	Dyspnea (Shortness of Breath) 01/2024
1	Hydrocephalus (Hydrocephaly) 01/2024
1	Retinal Hemorrhage 10/2023
1	Eye Diseases (Eye Disease) 10/2023
1	Pathologic Neovascularization 10/2023
1	Hypoxia (Hypoxemia) 10/2023
1	Conjunctivitis 01/2023
1	Atopic Dermatitis (Atopic Eczema) 11/2021
1	Dermatitis 11/2021
1	Nasal Polyps (Nasal Polyp) 09/2021
1	Rhinosinusitis 09/2021
1	Hyperplasia 09/2021
1	Parasomnias (Parasomnia) 11/2020
1	Arthritis (Polyarthritis) 01/2019
1	Acute Lung Injury 01/2019
1	Obesity 01/2019
1	Insulin Resistance 01/2019
1	Disease Progression 12/2018
1	Ureteral Obstruction 01/2017
1	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2015
1	Alzheimer Disease (Alzheimer's Disease) 04/2014
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2012
1	Fibrosis (Cirrhosis) 11/2012
1	Ulcerative Colitis 03/2011
1	Gastritis 12/2009
1	Polymyositis 05/2009
1	Necrosis 05/2009
1	Muscular Dystrophies (Muscular Dystrophy) 05/2009
1	Pneumonia (Pneumonitis) 03/2009
1	Stab Wounds (Stab Wound) 03/2009
1	Pathologic Processes 02/2009

Drug/Important Bio-Agent (IBA)

7	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 01/2024 - 05/2009
7	Prostaglandin D2IBA 10/2023 - 01/2017
6	ProstaglandinsIBA 10/2023 - 05/2009
5	LipocalinsIBA 01/2024 - 12/2009
4	LipidsIBA 01/2023 - 01/2017
3	AcidsIBA 01/2023 - 01/2019
3	Prostaglandins DIBA 11/2012 - 03/2009
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2021 - 01/2021
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2021 - 03/2011
2	Dextrans (Dextran)FDA Link 01/2021 - 03/2011
2	CytokinesIBA 12/2018 - 11/2012
2	EnzymesIBA 04/2014 - 03/2011
2	Prostaglandins FIBA 03/2009 - 02/2009
1	15-hydroxyeicosatrienoic acidIBA 01/2024
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Retinaldehyde (Retinal)IBA 10/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2023
1	Growth Factor ReceptorsIBA 10/2023
1	Evans Blue (Blue, Evans)FDA Link 01/2023
1	Coloring Agents (Dyes)IBA 01/2023
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2023
1	LipopolysaccharidesIBA 01/2023
1	OvalbuminIBA 01/2023
1	Dinoprostone (PGE2)FDA Link 01/2023
1	DinitrofluorobenzeneIBA 11/2021
1	SteroidsIBA 09/2021
1	11,15- dioxo- 9- hydroxy- 2,3,4,5- tetranorprostan- 1,20- dioic acidIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 11/2020
1	CholesterolIBA 01/2019
1	Fatty Acid-Binding ProteinsIBA 01/2019
1	AdiponectinIBA 01/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	ChemokinesIBA 12/2018
1	ColforsinIBA 01/2017
1	IronIBA 10/2015
1	Divalent CationsIBA 10/2015
1	CopperIBA 10/2015
1	ManganeseIBA 10/2015
1	Amyloid beta-PeptidesIBA 04/2014
1	Interleukin-4 (Interleukin 4)IBA 11/2012
1	Interleukin-13IBA 11/2012
1	Small Interfering RNA (siRNA)IBA 06/2012
1	Cre recombinaseIBA 06/2012
1	Drinking WaterIBA 03/2011
1	Messenger RNA (mRNA)IBA 12/2009
1	DystrophinIBA 05/2009
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 05/2009
1	Proteins (Proteins, Gene)FDA Link 05/2009
1	Prostaglandins EIBA 03/2009
1	AntigensIBA 03/2009

Therapy/Procedure

2	Oral Administration 01/2021 - 11/2012
1	Intranasal Administration 01/2024
1	Therapeutics 09/2021